iShares Global Healthcare ETF (NYSEARCA:IXJ) Reaches New 52-Week High – What’s Next?

iShares Global Healthcare ETF (NYSEARCA:IXJ) shares reached a new 52-week high during mid-day trading on Thursday. The company traded as high as $112.02 and last traded at $111.5810, with a volume of 16,414 shares. The stock had previously closed at $109.36.

iShares Global Healthcare ETF Stock Performance

The stock’s 50 day moving average price is $104.81 and its 200-day moving average price is $99.02. The company has a market cap of $4.65 billion, a PE ratio of 21.58 and a beta of 0.55.

Institutional Trading of iShares Global Healthcare ETF

A number of institutional investors have recently made changes to their positions in the stock. Envestnet Asset Management Inc. lifted its holdings in iShares Global Healthcare ETF by 45.2% in the second quarter. Envestnet Asset Management Inc. now owns 148,494 shares of the company’s stock worth $14,609,000 after buying an additional 46,194 shares during the period. Royal Fund Management LLC grew its holdings in shares of iShares Global Healthcare ETF by 4.8% during the 3rd quarter. Royal Fund Management LLC now owns 101,993 shares of the company’s stock worth $10,416,000 after acquiring an additional 4,668 shares during the period. Miller Howard Investments Inc. NY purchased a new position in shares of iShares Global Healthcare ETF during the 3rd quarter worth approximately $8,796,000. FCA Corp TX raised its position in shares of iShares Global Healthcare ETF by 1.3% in the 1st quarter. FCA Corp TX now owns 51,406 shares of the company’s stock worth $4,809,000 after acquiring an additional 678 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of iShares Global Healthcare ETF in the 3rd quarter worth approximately $4,881,000.

iShares Global Healthcare ETF Company Profile

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.